Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective Validation of the "Shamir Resistance Calculator": an Interventional Crossover Trial to Improve Empiric Prescription of Antimicrobials in Acute Care Hospitals.

NCT05304221 is registered in ClinicalTrials.gov with Dror MarChaim, MD as lead sponsor.

NCT NCT05304221
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05304221 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective Validation of the "Shamir Resistance Calculator": an Interventional Crossover Trial to Improve Empiric Prescription of Antimicrobials in Acute Care Hospitals.
Lead sponsor
Dror MarChaim, MD
Phase
Observational
Overall status
Unknown status
Start date
July 3, 2023
Completion date
January 31, 2025
Enrollment
1,500 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

sepsis